Skip to main content

Greenland Capital Management LP

Position in LQDA — Liquidia Corp

CIK 1896430 NEW YORK, NY

Position in LQDA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$5,661,000
+$1,125,565 QoQ
Shares Held
150,000
+14.1% QoQ
Ownership
0.169%
of shares outstanding
% of Portfolio
1.34%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in LQDA Over Time

Shares Held

Position Value (USD)

Derivatives in LQDA

reported options exposure · as of Mar 31, 2026
CallValue
$2,415,360
CallShares
64,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Greenland Capital Management LP holds $8,898,900 across 2 Drug Manufacturers - Specialty & Generic names. LQDA ranks #1 (63.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LQDA
Liquidia Corp
This page
150,000 $5,661,000

All Filings in LQDA

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,661,000 150,000
2026-03-31 $2,415,360 64,000
2025-12-31 $4,535,435 131,500
2025-12-31 $1,207,150 35,000
2025-09-30 $1,239,330 54,500
2025-09-30 $4,314,414 189,728
2025-06-30 $903,350 72,500
2025-06-30 $529,550 42,500
2025-03-31 $958,750 65,000
2025-03-31 $663,750 45,000
2024-12-31 $241,080 20,500
2024-12-31 $588,000 50,000